Endpoints at 30 and 180 days in the non-ventilated cohort
| Cohort B | Cohort H | P value | |
| Death 30 days | 36 (6.0%) | 30 (5.2%) | 0.59 |
| Death 180 days | 44 (7.3%) | 43 (7.5%) | 0.89 |
| CVA 30 days | 1 (0.2%) | 2 (0.4%) | 0.53 |
| TLF 30 days | 12 (2.0%) | 9 (1.6%) | 0.59 |
| Definite ST 30 days | 3 (0.5%) | 1 (0.2%) | 0.34 |
| Bleeding all 30 days | 132 (21.9%) | 114 (17.9%) | 0.10 |
| Bleeding BARC≥2 30 days | 91 (15.1%) | 92 (16.1%) | 0.64 |
| Bleeding BARC 2 30 days | 78 (12.9%) | 83 (14.5%) | 0.09 |
| Bleeding BARC 3 30 days | 10 (1.7%) | 9 (1.6%) | 0.83 |
| Bleeding BARC 4 30 days | 1 | 0 | – |
| Bleeding BARC 5 30 days | 2 | 0 | – |
CVA, cerebrovascular accident; ST, stent thrombosis; TLF, target lesion failure.